Yellow evolution is here with gene editing Monkey Flower
Monkeyflowers glow in a rich assortment of colors, from yellow to pink to deep red-orange. But about 5 million years ago, some of them lost their yellow. In the Feb. 10 issue of Science, UConn botanists explain what happened genetically to jettison…
HIV infection leaves a ‘memory’ in cells
Though antiretroviral therapy has made HIV a manageable disease, people living with HIV often suffer from chronic inflammation. This can put them at an increased risk of developing comorbidities such as cardiovascular disease and neurocognitive dysfunction, impacting the longevity and…
A key brain protein plays role in childhood movement disorder
Scientists at the UNC School of Medicine and UNC Eshelman School of Pharmacy, in collaboration with a team from Queen Mary University of London, have illuminated the molecular events underlying an inherited movement and neurodegenerative disorder known as ARSACS – Autosomal recessive…
Chronic Inflammation responsible for Vit-D Deficiency
Inflammation is an essential part of the body’s healing process. But when it persists, it can contribute to a wide range of complex diseases including type 2 diabetes, heart disease, and autoimmune diseases. Now, world-first genetic research from the University of South Australia shows a…
Engineered E. coli can Survive to Treat Diseases
Scientists have long tried to introduce genetically engineered bacteria into the gut to treat diseases. In the past, these attempts have focused on engineering common lab strains of E. coli, which cannot compete with the native gut bacteria that are well…
First Synthetic Mechanosensitive Potassium Channel is Here!
Intrigued by the properties of ion channel proteins commonly observed in cells, Tokyo Tech researchers have developed the first synthetic mechanosensitive potassium channel using a newly developed aromatic fluorinated amphiphilic cyclophane. Displaying both “stimuli responsiveness” and “selective ion transport” abilities,…
7 deaths, halts phase II clinical trial of MicroGenics
Recently, the death of seven patients in a Phase II trial of MicroGeniccs led to halt the testing. The trial was trying to assess the first line treatment drugs for patients with recurrent or metastatic squamous cell carcinoma of the…
Fixed vial sizes for controversial Alzheimer’s drug could waste $605 million in Medicare spending each year
Medicare could waste up to $605 million per year on the controversial Alzheimer’s drug aducanumab if it is eventually approved for widespread use because it is supplied in vials containing fixed doses that may not be appropriate for all patients–resulting…
Common antiretroviral drug improves cognition in mouse model of Down syndrome
Lamivudine, a commonly-used antiretroviral drug for treating HIV, improves cognition in a mouse model of Down syndrome, according to the findings of a joint new study by researchers at the Centre for Genomic Regulation (CRG) and the IrsiCaixa AIDS Research…
Gene variants may affect length of survival in Parkinson’s patients, new study shows
Scientists from four institutes in Paris, including the prestigious Paris Brain Institute at the Sorbonne Université, studied the records of 2,037 Parkinson’s disease patients from their first hospital visit and believe the genetic variants may shed light in how fast…
